U.S. Government Updates HIV Treatment Guidelines for Children

The U.S. Food and Drug Administration (FDA) recently announced the release of the latest revision of the federal Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection.

The new version does not depart dramatically from the previous version, but does include updated information on:

Recommended antiretroviral regimens for initial therapy.

Renewed recommendations regarding nelfinavir (Viramune), which now meets FDA limits for ethyl methane sulfonate (EMS).

The full revised guidelines are available online from the Pediatric Guidelines section of the AIDSinfo Web site. Changes in this revision are highlighted in yellow throughout the text and tables. There is also a new version of Supplement I: Pediatric Antiretroviral Drug Information.

Interested individuals may also request to received the guidelines by mail or email from the AIDSinfo Order Publications section.

8/19/08

Source
Pediatric Antiretroviral Guidelines Working Group. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Revised July 29. 2008.